ArticleNature medicine2023
Author Correction: Oncolytic T-VEC virotherapy plus neoadjuvant chemotherapy in nonmetastatic triple-negative breast cancer: a phase 2 trial.
Hatem Soliman et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it